Karen F. Murray, MD

"I love my work because I have so many opportunities to make a difference. Our team treats children with life-threatening diseases of the liver and digestive system that prevent them from realizing their full potential. It’s a complete thrill to give these kids and their families the care and compassion they need to achieve their life’s dreams. I also have the privilege of being a mentor. Educating the next generation of doctors and helping them meet their goals is a personal passion and vital to the future of medicine. And I’m excited to be involved in research about pediatric liver diseases and their treatment options, which we hope one day will enable us to prevent these terrible illnesses."

  • She completed a clinical and research fellowship in gastroenterology and nutrition in the combined program at Children’s Hospital Boston and Massachusetts General Hospital, Harvard Medical School. Murray is certified in gastroenterology and transplant hepatology, and chairs the Gastroenterology Sub-board of the American Board of Pediatrics. In addition to clinical care in gastroenterology and transplantation, she has an active clinical research program in hepatology. Her main focus is in the treatment and pathophysiology of childhood liver disease, with focus on the treatment of hepatitis B and C viral infections, non-alcoholic fatty liver disease, and cholestatic liver diseases in childhood. Murray is past-president of Seattle Children’s medical staff. She is on the steering committees of three National Institute of Diabetes and Digestive and Kidney Diseases clinical research networks related to her research. She mentors pediatrics residents and speaks at Seattle Children’s noon conferences.

    • Related Resources

    • Related Pages

    • Curing Hepatitis C in Kids

      Dr. Karen Murray led the charge to wipe out the virus by bringing two highly effective adult drugs to infected children.

  • Award Name Award Description Awarded By Award Date
    SEATTLE'S TOP DOCTOR - 2019 Seattle Magazine 2019
    SEATTLE'S TOP DOCTOR - 2018 Seattle Magazine 2018
    SEATTLE'S TOP DOCTOR - 2017 Seattle Magazine 2017
    Seattles Top Doctor 2016 Seattle Met Magazine 2016
    SEATTLE MAGAZINE TOP DOCTOR - 2016 Seattle Magazine 2016
    SEATTLE'S TOP DOCTOR - 2015 Seattle Met Magazine 2015
    SEATTLE MAGAZINE TOP DOCTOR - 2015 Seattle Magazine 2015
    1 of 2 Candidates for President of NASPGHAN Selected as 1 of 2 candidates for President of the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), a society of approximately 3,000 members across the USA, Canada, and Mexico. NASPGHAN 2014
    U.S. News Top Doctor U.S. News and World Report-ranked in top 1% 2012
    Best Doctors in America 2011
    Who's Who in America 2011
    International Association of Pediatricians 2010
    Leading Physicians of the World International Association of Healthcare Professionals 2010
    Seattle Magazine "Top Doctor" Seattle Magazine 2010 - 2014
    SEATTLE TOP DOCTORS Seattle Metropolitan Magazine 2010 - 2014
    Seattles Top Doctors Seattle Metropolitan Magazine 2006 - 2014
    Seattle Magazine "Top Doctor" Seattle Magazine. 2006
  • Other Publications

    • Younossi ZM, Stepanova M, Schwarz KB, Wirth S, Rosenthal P, Gonzalez-Peralta R, Murray K, Henry L, Hunt S
      Quality of Life in Adolescents with Hepatitis C Treated with Sofosbuvir and Ribavirin.
      29193603 Journal of viral hepatitis, 2017 Nov. 28
    • Wirth S, Rosenthal P, Gonzalez-Peralta RP, Jonas MM, Balistreri WF, Lin CH, Hardikar W, Kersey K, Massetto B, Kanwar B, Brainard DM, Shao J, Svarovskaia E, Kirby B, Arnon R, Murray KF, Schwarz KB
      Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection.
      28543053 Hepatology (Baltimore, Md.), 2017 Oct. : 66(4)1102-1110
    • Younossi ZM, Stepanova M, Balistreri W, Schwarz K, Murray KF, Rosenthal P, Bansal S, Hunt S
      Health-Related Quality of Life in Adolescent Patients with Hepatitis C Genotype 1 Treated with Sofosbuvir and Ledipasvir.
      28957984 Journal of pediatric gastroenterology and nutrition, 2017 Sept. 27
    • Ye W, Narkewicz MR, Leung DH, Karnsakul W, Murray KF, Alonso EM, Magee JC, Schwarzenberg SJ, Weymann A, Molleston JP, CFLDnet research group.
      Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis.
      28906321 Journal of pediatric gastroenterology and nutrition, 2017 Sept. 12
    • Perito ER, Ajmera V, Bass NM, Rosenthal P, Lavine JE, Schwimmer JB, Yates KP, Diehl AM, Molleston JP, Murray KF, Scheimann A, Gill R, Glidden D, Aouizerat B
      Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease.
      29130075 Hepatology communications, 2017 Sept. : 1(7)609-622 PMCID:PMC5679472
    • Balistreri WF, Murray KF, Rosenthal P, Bansal S, Lin CH, Kersey K, Massetto B, Zhu Y, Kanwar B, German P, Svarovskaia E, Brainard DM, Wen J, Gonzalez-Peralta RP, Jonas MM, Schwarz K
      The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.
      27997679 Hepatology (Baltimore, Md.), 2017 Aug. : 66(2)371-378
    • Newton KP, Feldman HS, Chambers CD, Wilson L, Behling C, Clark JM, Molleston JP, Chalasani N, Sanyal AJ, Fishbein MH, Lavine JE, Schwimmer JB, Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN).
      Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children.
      28366357 The Journal of pediatrics, 2017 Aug. : 187141-146.e1 PMCID:PMC5533631
    • Lane E, Murray KF
      Neonatal Cholestasis.
      28502442 Pediatric clinics of North America, 2017 June : 64(3)621-639
    • Schwarzenberg SJ, Ling SC, Cloonan YK, Lin HS, Evon DM, Murray KF, Rodriguez-Baez N, Rosenthal P, Teckman J, Schwarz KB, Hepatitis B Research Network.
      Health-related Quality of Life in Pediatric Patients With Chronic Hepatitis B Living in the United States and Canada.
      28169971 Journal of pediatric gastroenterology and nutrition, 2017 May : 64(5)760-769 PMCID:PMC5403561
    • Saubermann LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM
      Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees.
      27984347 Journal of pediatric gastroenterology and nutrition, 2017 April : 64(4)639-652
    • Africa JA, Behling CA, Brunt EM, Zhang N, Luo Y, Wells A, Hou J, Belt PH, Kohil R, Lavine JE, Molleston JP, Newton KP, Whitington PF, Schwimmer JB, Nonalcoholic Steatohepatitis Clinical Research Network.
      In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.
      28286193 Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017 March 7 : PMCID:PMC5589478
    • Bigham GN, Murray KJ, Masue-Slowey Y, Henry EA
      Biogeochemical controls on methylmercury in soils and sediments: Implications for site management.
      27427265 Integrated environmental assessment and management, 2017 March : 13(2)249-263
    • Murray KF
      Hepatitis C Virus Infection in Children.
      28539847 Gastroenterology and hepatology, 2017 March : 13(3)184-187 PMCID:PMC5439139
    • Barrett DJ, McGuinness GA, Cunha CA, Emans SJ, Gerson WT, Hazinski MF, Lister G, Murray KF, St Geme JW 3rd, Whitley-Williams PN
      Pediatric Hospital Medicine: A Proposed New Subspecialty.
      28246349 Pediatrics, 2017 March : 139(3)
    • Shneider BL, Moore J, Kerkar N, Magee JC, Ye W, Karpen SJ, Kamath BM, Molleston JP, Bezerra JA, Murray KF, Loomes KM, Whitington PF, Rosenthal P, Squires RH, Guthery SL, Arnon R, Schwarz KB, Turmelle YP, Sherker AH, Sokol RJ, Childhood Liver Disease Research Network.
      Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia?
      28493866 PloS one, 2017 : 12(5)e0176275 PMCID:PMC5426590
    • Nelson JE, Handa P, Aouizerat B, Wilson L, Vemulakonda LA, Yeh MM, Kowdley KV, NASH Clinical Research Network.
      Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.
      27730688 Alimentary pharmacology and therapeutics, 2016 Dec. : 44(11-12)1253-1264 PMCID:PMC5118184
    • Schwimmer JB, Lavine JE, Wilson LA, Neuschwander-Tetri BA, Xanthakos SA, Kohli R, Barlow SE, Vos MB, Karpen SJ, Molleston JP, Whitington PF, Rosenthal P, Jain AK, Murray KF, Brunt EM, Kleiner DE, Van Natta ML, Clark JM, Tonascia J, Doo E, NASH CRN.
      In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.
      27569726 Gastroenterology, 2016 Dec. : 151(6)1141-1154.e9 PMCID:PMC5124386
    • McGowan JE, Murray K
      Exploring resilience in nursing and midwifery students: a literature review.
      27005469 Journal of advanced nursing, 2016 Oct. : 72(10)2272-83
    • Almeida OP, Marsh K, Murray K, Hickey M, Sim M, Ford A, Flicker L
      Reducing depression during the menopausal transition with health coaching: Results from the healthy menopausal transition randomised controlled trial.
      27621237 Maturitas, 2016 Oct. : 9241-48
    • Li R, Belle SH, Horslen S, Chen LW, Zhang S, Squires RH, Pediatric Acute Liver Failure Study Group.
      Clinical Course among Cases of Acute Liver Failure of Indeterminate Diagnosis.
      26831743 The Journal of pediatrics, 2016 April : 171163-70.e1-3 PMCID:PMC4808594
    • Murray K, Yasso S, Schomburg R, Terhune M, Beidelschies M, Bowers D, Goodyear-Bruch C
      Journey of Excellence: Implementing a Shared Decision-Making Model.
      27011138 The American journal of nursing, 2016 April : 116(4)50-6
    • Shneider BL, Magee JC, Karpen SJ, Rand EB, Narkewicz MR, Bass LM, Schwarz K, Whitington PF, Bezerra JA, Kerkar N, Haber B, Rosenthal P, Turmelle YP, Molleston JP, Murray KF, Ng VL, Wang KS, Romero R, Squires RH, Arnon R, Sherker AH, Moore J, Ye W, Sokol RJ, Childhood Liver Disease Research Network (ChiLDReN).
      Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia.
      26725209 The Journal of pediatrics, 2016 March : 170211-7.e1-2 PMCID:PMC4826612
    • Murray KE, Ressler KJ, Owens MJ
      In vivo investigation of escitalopram's allosteric site on the serotonin transporter.
      26621784 Pharmacology, biochemistry, and behavior, 2016 Feb. : 14150-7 PMCID:PMC4724252
    • Boehm PD, Murray KJ, Cook LL
      Distribution and Attenuation of Polycyclic Aromatic Hydrocarbons in Gulf of Mexico Seawater from the Deepwater Horizon Oil Accident.
      26721562 Environmental science and technology, 2016 Jan. 19 : 50(2)584-92
    • Narkewicz MR, Rosenthal P, Schwarz KB, Drack A, Margolis T, Repka MX
      Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon.
      20512062 Journal of pediatric gastroenterology and nutrition, 2010 Aug. : 183-6
    • Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen AR, Krishnan A, Kernan NA, Avigan DE, Spitzer TR, Shulman HM, Di Salvo DN, Revta C, Warren D, Momtaz P, Bradwin G, Wei LJ, Iacobelli M, McDonald GB, Guinan EC
      Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.
      20167278 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010 July : 1005-17
    • Wahbeh G, Rubens D, Katz JR, Seidel K, Rampersad SE, Murray KF
      Gastric contents in pediatric patients following bone marrow transplantation.
      20456059 Paediatric anaesthesia, 2010 July : 660-5
    • Sadilek M, Feldman K, Murray KF, Young M, Mazor S
      Detection of polyethylene glycol-based laxatives in stool.
      20118809 Journal of pediatric gastroenterology and nutrition, 2010 March : 276-9
    • Laiko M, Murtazina R, Malyukova I, Zhu C, Boedeker EC, Gutsal O, O'Malley R, Cole RN, Tarr PI, Murray KF, Kane A, Donowitz M, Kovbasnjuk O
      Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3.
      19744479 Experimental cell research, 2010 Feb. 15 : 657-66
    • Mohan N, González-Peralta RP, Fujisawa T, Chang MH, Heller S, Jara P, Kelly D, Mieli-Vergani G, Shah U, Murray KF
      Chronic hepatitis C virus infection in children.
      20038846 Journal of pediatric gastroenterology and nutrition, 2010 Feb. : 123-31
    • Lavine JE, Schwimmer JB, Molleston JP, Scheimann AO, Murray KF, Abrams SH, Rosenthal P, Sanyal AJ, Robuck PR, Brunt EM, Unalp A, Tonascia J
      Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.
      19761871 Contemporary clinical trials, 2010 Jan. : 62-70
    • Karen F. Murray, MD, Ed Murray KF, Larson AM
      Fibrocystic diseases of the liver, 1st edition
      2010 : 511 pages
    • Narkewicz MR, Dell Olio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, Zhang S, Belle SH, Squires RH
      Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement.
      19643443 The Journal of pediatrics, 2009 Dec. : 801-806.e1
    • Haber BA, Block JM, Jonas MM, Karpen SJ, London WT, McMahon BJ, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB
      Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B.
      19805457 Pediatrics, 2009 Nov. : e1007-13
    • Mieli-Vergani G, Heller S, Jara P, Vergani D, Chang MH, Fujisawa T, González-Peralta RP, Kelly D, Mohan N, Shah U, Murray KF
      Autoimmune hepatitis.
      19561543 Journal of pediatric gastroenterology and nutrition, 2009 Aug. : 158-64
    • Shah U, Kelly D, Chang MH, Fujisawa T, Heller S, González-Peralta RP, Jara P, Mieli-Vergani G, Mohan N, Murray KF
      Management of chronic hepatitis B in children.
      19322053 Journal of pediatric gastroenterology and nutrition, 2009 April : 399-404
    • Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Schwarz KB, Robuck P, Barton B, González-Peralta RP
      Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes.
      19242286 Journal of pediatric gastroenterology and nutrition, 2009 March : 341-7
    • Malyukova I, Murray KF, Zhu C, Boedeker E, Kane A, Patterson K, Peterson JR, Donowitz M, Kovbasnjuk O
      Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.
      18974311 American journal of physiology. Gastrointestinal and liver physiology, 2009 Jan. : G78-92
    • Murray KF, Hadzic N, Wirth S, Bassett M, Kelly D
      Drug-related hepatotoxicity and acute liver failure.
      18852631 Journal of pediatric gastroenterology and nutrition, 2008 Oct. : 395-405
    • McGinnis JK, Murray KF
      Infliximab for ulcerative colitis in children and adolescents.
      18645529 Journal of clinical gastroenterology, 2008 Sept. : 875-9
    • Murray KF, Shah U, Mohan N, Heller S, González-Peralta RP, Kelly D, Chang MH, Mieli-Vergani G, Jara P, Fujisawa T
      Chronic hepatitis.
      18664880 Journal of pediatric gastroenterology and nutrition, 2008 Aug. : 225-33
    • Bassett MD, Murray KF
      Biliary atresia: recent progress.
      18496390 Journal of clinical gastroenterology, 2008 July : 720-9
    • Hsu EK, Murray KF
      Hepatitis B and C in children.
      18414457 Nature clinical practice. Gastroenterology & hepatology, 2008 June : 311-20
    • Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR, Schwarz KB
      Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
      18167062 Hepatology (Baltimore, Md.), 2008 March : 836-43
    • Suskind DL, Murray KF
      Increasing the mutation rate for Jagged1 mutations in patients with Alagille syndrome.
      17661408 Hepatology (Baltimore, Md.), 2007 Aug. : 598-9
    • Murray KF, Rodrigue JR, González-Peralta RP, Shepherd J, Barton BA, Robuck PR, Schwarz KB
      Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection.
      18042575 Clinical trials (London, England), 2007 : 661-73
    • Murray KF
      Autoimmune hepatitis: are we using the right therapy?
      17204947 Journal of pediatric gastroenterology and nutrition, 2007 Jan. : 18-9
    • Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, Rosenthal P, Rodriguez-Baez N, Murray KF, Horslen S, Martin MG, Lopez MJ, Soriano H, McGuire BM, Jonas MM, Yazigi N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine JE, Karpen S, Ng V, Kelly D, Simonds N, Hynan LS
      Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group.
      16737880 The Journal of pediatrics, 2006 May : 652-658
    • Dinulos JG, Darmstadt GL, Len MK, Rutledge JC, Murray KF
      Infantile Crohn disease presenting with diarrhea and pyoderma gangrenosum.
      16445411 Pediatric dermatology, 2006 Jan. : 43-8
    • González-Peralta RP, Kelly DA, Haber B, Molleston J, Murray KF, Jonas MM, Shelton M, Mieli-Vergani G, Lurie Y, Martin S, Lang T, Baczkowski A, Geffner M, Gupta S, Laughlin M
      Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics.
      16250032 Hepatology (Baltimore, Md.), 2005 Nov. : 1010-8
    • Murray KF, Finn LS, Taylor SL, Seidel KD, Larson AM
      Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection.
      16254522 Journal of pediatric gastroenterology and nutrition, 2005 Nov. : 634-8
    • Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, Goldin B, Hartigan L, Kugathasan S, Levy J, Murray KF, Oliva-Hemker M, Rosh JR, Tolia V, Zholudev A, Vanderhoof JA, Hibberd PL
      A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.
      16116318 Inflammatory bowel diseases, 2005 Sept. : 833-9
    • Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI
      Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
      15930195 Pediatrics, 2005 June : e673-80
    • Murray KF, Carithers RL Jr
      AASLD practice guidelines: Evaluation of the patient for liver transplantation.
      15880505 Hepatology (Baltimore, Md.), 2005 June : 1407-32
    • Murray KF, Lam D, Kowdley KV
      Current and future therapy in haemochromatosis and Wilson's disease.
      14640923 Expert opinion on pharmacotherapy, 2003 Dec. : 2239-51
    • Murray KF, Richardson LP, Morishima C, Owens JW, Gretch DR
      Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study.
      12509569 Pediatrics, 2003 Jan. : 153-7

  • Presentations Title Event Location Date
    Concurrent Session III speaker: “Why do maintenance of certification?”; Faculty, 4th Hands on Endoscopy Course - Polypectomy Orlando, FL NASPGHAN Annual Meeting 2011
    "Drug-induced liver injury and liver failure in children” Taiwan Society of Pediatric Gastroenterology, Hepatology, and Nutrition annual meeting Taipei, Taiwan 2011
    “Gastroenterology: Careers in Academic Pediatric Gastroenterology and Hepatology” Pediatric Academic Societies Vancouver, Canada 2010
    “Biliary Atresia: Clinical Spectrum and Mechanisms of Disease"; • “New Treatments for Chronic B and C Hepatitis”; “State of the Art in Non-Alcoholic Steatohepatitis” International Symposium of Argentine Association for the Study of Liver Diseases (AAEEH) - International Guest Pediatric Hepatologist Buenos Aires, Argentina 2010
  • Grant Title Grantor Amount Award Date
    A Phase 3, Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection Gilead Sciences, Inc. $56,849.00 Jan. 1, 2009
    Childhood Liver Disease Research and Education Network Clinical Center in Seattle NIH NIDDK $1,557,754.00 Jan. 1, 2009
    Limited Competition: Continuation of the Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN) NIH $225,207.00 Jan. 1, 2009
    Clinical Research Network in Hepatitis B Virus NIH $311,878.00 Jan. 1, 2008
    BARC CRN, Biliary atresia research consortium NIH NIDDK $95,266.00 Jan. 1, 2008
    A phase 3 double-blind, randomized, placebo-controlled study of the safety and efficacy of Adefovir Dipivoxil in children and adolescents (age 2 to under 18) with chronic hepatitis B Gilead Sciences, Inc. $128,327.00 Jan. 1, 2004
    Pegylated interferon + - ribavirin for children with HCV FDA-OPD-2002 Clinical Studies of Safety and Effectiveness of Orphan Products $99,650.00 Jan. 1, 2003
    CD4+ T-cell immunity in mother-child pairs infected with hepatitis C virus Research Endorsement Fund $30,000.00 Jan. 1, 2002
    Pediatric Acute liver failure study group NIH/NIDDK $16,000.00


Medical/Professional School

Johns Hopkins University School of Medicine, Baltimore


Pediatrics, Children's Hospital and Regional Medical Center, Seattle


Gastroenterology, Children's Hospital, Boston
Pediatric Gastroenterology, Massachusetts General Hospital, Boston

Clinical Interests

Hepatitis B and C

Research Description

Clinical research in the pathogenesis of, epidemiology of, and treatment for viral hepatitis and other pediatric liver diseases.

Research Focus Area

Translational research, observational studies, investigator-initiated interventional studies, Therapeutic Trials